WHO ICTRP trial
Studying the effect of medication (sacubitril/valsartan) on heart muscle damage…
EUCTR2017-003460-13-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-003460-13-GB |
|---|---|
| Public title | Studying the effect of medication (sacubitril/valsartan) on heart muscle damage after heart attacks |
| Scientific title | The effects of sacubitril/valsartan compared to valsartan on left ventricular remodelling in patients with asymptomatic left ventricular systolic dysfunction after myocardial infarction: a randomised, double-blinded, active-comparator, cardiac-MR based trial. - RECOVER-LV |
| Primary sponsor | NHS Greater Glasgow and Clyde |
| Secondary sponsors | University of Glasgow |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Asymptomatic (New York Heart Association =2) left ventricular systolic dysfunction (defined as ejection fraction =40% measured by Simpson's biplane using transthoracic echocardiography) at least 3 months post myocardial infarction MedDRA… |
| Interventions | Trade Name: Entresto Product Name: Entresto Pharmaceutical Form: Tablet INN or Proposed INN: Sacubitril/Valsartan CAS Number: 149709-62-6 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 24/26- INN or… |
| Registration date | Aug 6, 2018 |
| Target size | 100 |
| Secondary IDs | GN16CA007 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: